P148 Comparison of cyclophosphamide and rituximab in the treatment of severe systemic lupus erythematosus

P148 Comparison of cyclophosphamide and rituximab in the treatment of severe systemic lupus erythematosus

Bibliographic Details
Main Authors:	László Kovács, Gergely Bodor, Martin Takács
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

Rituximab in the management of systemic lupus erythematosus
by: Adrian Levitsky, et al.
Published: (2013-06-01)

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus
by: Mariana Álvares Penha, et al.
Published: (2018-06-01)

Rituximab for treatment of severe lupus nephritis
by: Baskin E, et al.
Published: (2008-09-01)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
by: Miettunen PM, et al.
Published: (2008-09-01)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
by: López Longo J, et al.
Published: (2010-11-01)

Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus
by: Victoria L. Wolf, et al.
Published: (2019-05-01)

Premature ovarian failure in systemic lupus erythematosus patients: is it related to cyclophosphamide treatment?
by: Rasha M Ghaleb, et al.
Published: (2019-01-01)

Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
by: Hao Cheng, et al.
Published: (2022-08-01)

Successful Treatment with Rituximab in a Patient with Castleman′s Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia
by: Lu Zhang, et al.
Published: (2015-01-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
by: Didem Atay, et al.
Published: (2012-03-01)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
by: Carreño L, et al.
Published: (2010-11-01)

Early addition of rituximab in the management of myositis associated with systemic lupus erythematosus
by: Mervat E Behiry, et al.
Published: (2019-01-01)

Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab
by: Vasudha V Sardesai, et al.
Published: (2015-01-01)

Refractory Orbital Myositis in Systemic Lupus Erythematosus - A Role for Rituximab
by: Joana Rodrigues Morais, et al.
Published: (2021-12-01)

Efficacy of high-dose methylprednisolone and cyclophosphamide in childhood-onset systemic lupus erythematosus
by: Putu Ayunda Trisnia, et al.
Published: (2020-04-01)

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab
by: Kazuya Abe, et al.
Published: (2019-10-01)

Successful treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Systemic Lupus Erythematosus (SLE) with oral cyclophosphamide
by: Jasmin, R., et al.
Published: (2012)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
by: Ashleigh Hennessey, et al.
Published: (2019-08-01)

Comparison of Plasma Cytokine Levels before and after Treatment with Rituximab in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus-Associated Polyautoimmunity
by: Julián Esteban Barahona Correa, et al.
Published: (2018-01-01)

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013-04-01)

LP-190 Successful treatment of rituximab and bortezomib in refractory systemic lupus erythematosus: a case report
by: Chen Chen, et al.
Published: (2023-07-01)

P164 Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: a single center experience
by: Serdal Ugurlu, et al.
Published: (2024-03-01)

P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB
by: S. McAdoo, et al.
Published: (2016-11-01)

Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report
by: L. Fioravante da Silveira, et al.
Published: (2023-07-01)

Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
by: Xiaowei Xu, et al.
Published: (2013-12-01)

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
by: M É Tsanian, et al.
Published: (2013-05-01)

Vesiculobullous disease with Cutaneous Systemic Lupus Erythematosus Treated by Rituximab: A case report
by: Wigdan Mohammed Niamat Alla, et al.
Published: (2021-10-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
by: Jones, R, et al.
Published: (2010)

Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis
by: Masoud Etemadifar, et al.
Published: (2020-02-01)

Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus
by: Ting-Wei Lin, et al.
Published: (2024-01-01)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01)

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
by: Francesca Faustini, et al.
Published: (2022-04-01)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
by: Leanna M. Wise, et al.
Published: (2020-06-01)

Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
by: Jevon Yudhishdran, et al.
Published: (2021-07-01)

Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus
by: Niaz Faraz, et al.
Published: (2010-01-01)

Rituximab in the treatment of refractory lupus nephritis with vasculitis
by: Huseyin Kadikoy, et al.
Published: (2012-01-01)

Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa
by: A.A. Akpabio, et al.
Published: (2020-07-01)